These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Alterations of the p53 tumor suppressor gene and its association with activation of the c-K-ras-2 protooncogene in premalignant and malignant lesions of the human uterine endometrium. Enomoto T, Fujita M, Inoue M, Rice JM, Nakajima R, Tanizawa O, Nomura T. Cancer Res; 1993 Apr 15; 53(8):1883-8. PubMed ID: 8385572 [Abstract] [Full Text] [Related]
6. ras gene activation and infrequent mutation in papillary serous carcinoma of the peritoneum. Garrett AP, Ng SW, Muto MG, Welch WR, Bell DA, Berkowitz RS, Mok SC. Gynecol Oncol; 2000 Apr 15; 77(1):105-11. PubMed ID: 10739698 [Abstract] [Full Text] [Related]
7. The role of oncogenes in human neoplasia. Aaronson SA, Tronick SR. Important Adv Oncol; 1985 Apr 15; ():3-15. PubMed ID: 3916746 [No Abstract] [Full Text] [Related]
13. The product of the cph oncogene is a truncated, nucleotide-binding protein that enhances cellular survival to stress. Velasco JA, Avila MA, Notario V. Oncogene; 1999 Jan 21; 18(3):689-701. PubMed ID: 9989819 [Abstract] [Full Text] [Related]
14. The involvement of oncogenes and suppressor genes in human neoplasia. Brodeur GM. Adv Pediatr; 1987 Jan 21; 34():1-44. PubMed ID: 3318293 [Abstract] [Full Text] [Related]
17. Mutations of K-ras oncogene and absence of H-ras mutations in squamous cell carcinomas of the lung. Vachtenheim J, Horáková I, Novotná H, Opáalka P, Roubková H. Clin Cancer Res; 1995 Mar 21; 1(3):359-65. PubMed ID: 9815992 [Abstract] [Full Text] [Related]